Article
Methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms and the risk of primary hepatocellular carcinoma (HCC) in a Chinese population.
Cancer causes & control : CCC - 1 Aug 2007
Mu Li-Na, Cao Wei, Zhang Zuo-Feng, Cai Lin, Jiang Qing-Wu, You Nai-Chieh, Goldstein Binh Yang, Wei Guo-Rong, Chen Chuan-Wei, Lu Qing-Yi, Zhou Xue-Fu, Ding Bao-Guo, Chang Jun, Yu Shun-Zhang
Abstract excerpt
OBJECTIVES: Methylenetetrahydrofolate reductase (MTHFR), which is expressed in the liver, may be involved in both DNA methylation and DNA synthesis. It is also indicated as a potential risk factor of liver cancer in patients with chronic liver disease. To date, no study has been conducted on MTHFR and hepatocellular carcinoma (HCC) using a population-based design. The objective of this study was to evaluate the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
